Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Analyze both dividend and price returns yearly to evaluate total performance and income potential from index fund investments.
28,655 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Oil markets jump as Iran keeps Strait Hormuz under pressure, signaling potential disruption to energy flows. Investor...
Mexico City's metro facelift for the World Cup has critics accusing officials of prioritizing aesthetics over essenti...
As MiCA tightens EU crypto rules, licensed platforms race to absorb deposits from non-compliant venues. european cryp...
Bitcoin's recent surge has sparked talk of a new bull leg. Yet Wintermute's warning — wintermute cautions 'relief ral...
US spot Bitcoin ETFs have shed about $8 billion since October, stoking a provocative debate on whether bitcoin etfs w...
Defi hacks turning high yields into a hidden tax are drawing fresh scrutiny, as Q2 losses from hacks totaled $780.3 m...
Retirement is a chance to design a life with purpose. Explore how varying activities nurture meaning and mental healt...
Russia is moving toward a broader embrace of its digital ruble, with key banks and merchants prepared to accept it by...
Online rumors can spread faster than facts and hit your wallet hard. This guide shows how smears become mainstream, t...
An AI forecast linked to Altman ChatGPT projects XRP moving into multi-dollar territory by late 2026, driven by regul...
Could buying oklo stock spark a life-changing return, or is it a high-stakes gamble? This guide breaks down what the ...